The goal of the medication is to allow you to focus on developing the lifestyle that food cravings have been stopping you from doing
Taking the wrong medication or incorrect dosage can exacerbate anxiety symptoms, cause adverse reactions, or lead to dependency
Additionally, the high prevalence and generally similar obesity-related complications in both cohorts suggest consistent clinical profiles of the patients who received these treatments
On the data side, the Lau phase 2 obesity trial showed Cagrilintide monotherapy producing dose-related weight loss, reaching close to 10.8 percent at the top dose over roughly 26 weeks, against about 3 percent on placebo
We encourage you to stay in close contact with our providers, attend your scheduled follow-ups, and maintain realistic expectations as your body adjusts to the medication
Matsumoto Y, Sato M, Ohashi H et al (2000) Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients